LANDMARK BIO Trademark

Trademark Overview

On Tuesday, July 6, 2021, a trademark application was filed for LANDMARK BIO with the United States Patent and Trademark Office. The USPTO has given the LANDMARK BIO trademark a serial number of 90813819. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, September 16, 2024. This trademark is owned by The Center for Advanced Biological Innovation and Manufacturing, PBLLC. The LANDMARK BIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases and disorders, genetic diseases and disorders, neurodegenerative diseases and disorders, and age-related diseases and disorders
landmark bio

General Information

Serial Number90813819
Word MarkLANDMARK BIO
Filing DateTuesday, July 6, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases and disorders, genetic diseases and disorders, neurodegenerative diseases and disorders, and age-related diseases and disorders
Pseudo MarkLANDMARK BIO
NOT AVAILABLE"BIO"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLANDMARK BIO, PBLLC
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressWatertown, MA 02472
Party NameThe Center for Advanced Biological Innovation and Manufacturing, PBLLC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressWatertown, MA 02472
Party NameThe Center for Advanced Biological Innovation and Manufacturing, PBLLC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Wednesday, September 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 9, 2021NEW APPLICATION ENTERED
Thursday, March 24, 2022ASSIGNED TO EXAMINER
Monday, March 28, 2022NON-FINAL ACTION WRITTEN
Monday, March 28, 2022NON-FINAL ACTION E-MAILED
Monday, March 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 1, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, November 28, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, December 5, 2022NON-FINAL ACTION WRITTEN
Monday, December 5, 2022NON-FINAL ACTION E-MAILED
Monday, December 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 19, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 3, 2023SOU EXTENSION 1 FILED
Wednesday, October 11, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, October 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 13, 2023SOU EXTENSION 1 GRANTED
Saturday, October 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 3, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, April 3, 2024SOU EXTENSION 2 FILED
Wednesday, April 3, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, April 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 21, 2024DIVISIONAL PROCESSING COMPLETE
Tuesday, May 21, 2024SOU EXTENSION 2 GRANTED
Wednesday, May 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 4, 2024CORRECTED NOA E-MAILED
Monday, September 16, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024SOU EXTENSION 3 FILED
Monday, September 16, 2024SOU EXTENSION 3 GRANTED

Related Keywords

landmark disorders diseases neurodegenerative related genetic preparations oncological pharmaceutical treatment